annual EBITDA:
-$342.21M-$101.72M(-42.30%)Summary
- As of today (August 20, 2025), DYN annual EBITDA is -$342.21 million, with the most recent change of -$101.72 million (-42.30%) on December 31, 2024.
- During the last 3 years, DYN annual EBITDA has fallen by -$193.28 million (-129.77%).
- DYN annual EBITDA is now -7048.80% below its all-time high of -$4.79 million, reached on December 31, 2018.
Performance
DYN EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
-$110.26M+$11.61M(+9.53%)Summary
- As of today (August 20, 2025), DYN quarterly EBITDA is -$110.26 million, with the most recent change of +$11.61 million (+9.53%) on June 30, 2025.
- Over the past year, DYN quarterly EBITDA has dropped by -$45.56 million (-70.41%).
- DYN quarterly EBITDA is now -1997.39% below its all-time high of -$5.26 million, reached on December 31, 2019.
Performance
DYN quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$434.01M-$45.56M(-11.73%)Summary
- As of today (August 20, 2025), DYN TTM EBITDA is -$434.01 million, with the most recent change of -$45.56 million (-11.73%) on June 30, 2025.
- Over the past year, DYN TTM EBITDA has dropped by -$171.40 million (-65.27%).
- DYN TTM EBITDA is now -7424.43% below its all-time high of -$5.77 million, reached on September 30, 2019.
Performance
DYN TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
DYN EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -42.3% | -70.4% | -65.3% |
| 3 y3 years | -129.8% | -110.8% | -138.8% |
| 5 y5 years | -2245.8% | -1167.8% | -2100.6% |
DYN EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -129.8% | at low | -177.4% | +9.5% | -156.4% | at low |
| 5 y | 5-year | -2245.8% | at low | -1167.8% | +9.5% | -2100.6% | at low |
| alltime | all time | -7048.8% | at low | -1997.4% | +9.5% | -7424.4% | at low |
DYN EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$110.26M(-9.5%) | -$434.01M(+11.7%) |
| Mar 2025 | - | -$121.87M(+26.1%) | -$388.45M(+15.8%) |
| Dec 2024 | -$342.21M(+42.3%) | -$96.66M(-8.1%) | -$335.35M(+9.6%) |
| Sep 2024 | - | -$105.22M(+62.6%) | -$305.98M(+16.5%) |
| Jun 2024 | - | -$64.70M(-5.9%) | -$262.61M(-0.6%) |
| Mar 2024 | - | -$68.77M(+2.2%) | -$264.21M(+9.9%) |
| Dec 2023 | -$240.49M(+42.1%) | -$67.29M(+8.8%) | -$240.49M(+12.9%) |
| Sep 2023 | - | -$61.84M(-6.7%) | -$212.94M(+10.3%) |
| Jun 2023 | - | -$66.31M(+47.2%) | -$192.98M(+7.8%) |
| Mar 2023 | - | -$45.05M(+13.4%) | -$178.97M(+5.7%) |
| Dec 2022 | -$169.28M | -$39.74M(-5.1%) | -$169.28M(-6.6%) |
| Sep 2022 | - | -$41.88M(-19.9%) | -$181.15M(-0.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$52.30M(+47.9%) | -$181.78M(+14.0%) |
| Mar 2022 | - | -$35.36M(-31.5%) | -$159.40M(+7.0%) |
| Dec 2021 | -$148.94M(+155.3%) | -$51.62M(+21.4%) | -$148.94M(+18.5%) |
| Sep 2021 | - | -$42.51M(+42.1%) | -$125.67M(+29.9%) |
| Jun 2021 | - | -$29.92M(+20.2%) | -$96.78M(+28.1%) |
| Mar 2021 | - | -$24.90M(-12.2%) | -$75.56M(+49.1%) |
| Dec 2020 | -$58.34M(+299.9%) | -$28.35M(+108.2%) | -$50.66M(+83.8%) |
| Sep 2020 | - | -$13.62M(+56.5%) | -$27.57M(+39.8%) |
| Jun 2020 | - | -$8.70M(+65.4%) | -$19.72M(+78.9%) |
| Dec 2019 | -$14.59M(+204.7%) | -$5.26M(-8.9%) | -$11.03M(+91.1%) |
| Sep 2019 | - | -$5.77M | -$5.77M |
| Dec 2018 | -$4.79M | - | - |
FAQ
- What is Dyne Therapeutics, Inc. annual EBITDA?
- What is the all time high annual EBITDA for Dyne Therapeutics, Inc.?
- What is Dyne Therapeutics, Inc. annual EBITDA year-on-year change?
- What is Dyne Therapeutics, Inc. quarterly EBITDA?
- What is the all time high quarterly EBITDA for Dyne Therapeutics, Inc.?
- What is Dyne Therapeutics, Inc. quarterly EBITDA year-on-year change?
- What is Dyne Therapeutics, Inc. TTM EBITDA?
- What is the all time high TTM EBITDA for Dyne Therapeutics, Inc.?
- What is Dyne Therapeutics, Inc. TTM EBITDA year-on-year change?
What is Dyne Therapeutics, Inc. annual EBITDA?
The current annual EBITDA of DYN is -$342.21M
What is the all time high annual EBITDA for Dyne Therapeutics, Inc.?
Dyne Therapeutics, Inc. all-time high annual EBITDA is -$4.79M
What is Dyne Therapeutics, Inc. annual EBITDA year-on-year change?
Over the past year, DYN annual EBITDA has changed by -$101.72M (-42.30%)
What is Dyne Therapeutics, Inc. quarterly EBITDA?
The current quarterly EBITDA of DYN is -$110.26M
What is the all time high quarterly EBITDA for Dyne Therapeutics, Inc.?
Dyne Therapeutics, Inc. all-time high quarterly EBITDA is -$5.26M
What is Dyne Therapeutics, Inc. quarterly EBITDA year-on-year change?
Over the past year, DYN quarterly EBITDA has changed by -$45.56M (-70.41%)
What is Dyne Therapeutics, Inc. TTM EBITDA?
The current TTM EBITDA of DYN is -$434.01M
What is the all time high TTM EBITDA for Dyne Therapeutics, Inc.?
Dyne Therapeutics, Inc. all-time high TTM EBITDA is -$5.77M
What is Dyne Therapeutics, Inc. TTM EBITDA year-on-year change?
Over the past year, DYN TTM EBITDA has changed by -$171.40M (-65.27%)